Depression is one of the major factors affecting quality of life in patients and there are a lot of psychostimulants used to overcome the disease pathology. A recent published in the American Journal of Psychiatry has reviewed the scientific evidence about this "cognition-enhancing" supplement further cautioning against its use as a dietary supplement.
Adrafinil is a psychostimulant prodrug of modafinil marketed as a dietary supplement with purported effects on concentration, productivity, cognition, and wakefulness, leading many individuals to take adrafinil without physician supervision. But what is the background medical evidence for this drug? Is it safe yet for over-the counter use?
For more information check out the full story on the link below: